Saxenda 3ml Liraglutide Injection Pen Manufacturer for sale
Accepted Payment Methods
Cryptocurrency

USDT, BTC (3% Discount)

Also accepts: CNY, USD, HKD, and 8 other currencies

Bank Transfer

Multiple international banking options available

Contact us for specific bank details

Categories ,

Saxenda 3ml Liraglutide Injection Pen Manufacturer for sale

$108.00

Wholesale Information
Quick Summary

MOQ: 100 boxes (1,000 pens) | Price: $108/pen | Lead Time: 7-45 days

Ordering Requirements
Minimum Order Quantity (MOQ)100 boxes (1,000 pens, 10 pens/box)
Repeat ClientsMay negotiate down to 50 boxes
Pricing & Volume Discounts
Order QuantityPrice per PenTotal Value
100-499 boxes$108.00$108,000
500-999 boxes$102.60 (5% discount)$102,600
1,000+ boxes$97.20 (10% discount)$97,200

Note: Prices exclude shipping and tariffs. Valid for 30 days from quote date.

Product Specifications
Formulation Details
  • Active Ingredient: Liraglutide 6 mg/ml (18mg per 3ml pen)
  • Excipients: Sodium phosphate dibasic dihydrate, propylene glycol, phenol
  • Appearance: Pre-filled multidose injection pen with clear solution
Packaging Configuration
Primary Packaging3ml pre-filled pens (10 pens/box)
Secondary Packaging20 boxes/case (200 pens total)
Case Dimensions40×30×25cm (L×W×H)
Gross Weight~5.5kg per case
Storage & Stability
  • Storage: Unopened: 2-8°C; In-use: ≤30°C for ≤30 days
  • Shelf Life: 24 months unopened
  • Stability: Maintain potency for 30 days after first use

Note: All product specifications are for reference only. Actual parameters may vary – please confirm with our sales team.

Logistics & Shipping
Production Lead Times
Standard Orders (In Stock)Ships within 7 business days
Custom Production30-45 days (requires 30% deposit)
Shipping Options
Express Air Freight3-7 days (recommended for urgent orders)
Ocean Freight20-40 days (cost-effective for bulk orders)
Manufacturing OriginGMP facilities in China (Made in China)
Cold Chain Management
Standard ShippingRefrigerated (2-8°C) with temperature monitoring
Hot Climate OptionInsulated packaging (+$50/case)
Temperature MonitoringData loggers included at no extra cost
Payment Terms
Accepted Payment Methods
Bank TransferIndustrial and Commercial Bank of China (ICBC)
CryptocurrencyUSDT, BTC (3% discount)
Other Currencies11 currencies including RMB, USD, HKD
Payment Conditions
  • First-time orders: 100% advance payment
  • Repeat clients: 50% deposit, 50% before shipment
  • Orders >$50,000: Eligible for installment plans (3 payments)
  • Custom production requires 30% non-refundable deposit

Note: Always provide payment confirmation via email after transaction.

Contact Us
"Focuses on large-scale purchases"
"Large-Volume Global Supply"
"Professional Wholesale Partnership"
Description

Saxenda™ 3ml Injection Pen

Liraglutide 6 mg/ml

Clinical Overview

Saxenda™ is an FDA-approved GLP-1 receptor agonist for chronic weight management. Clinical trials show 56% of patients achieved ≥5% weight loss at 56 weeks when combined with lifestyle changes. The 3ml pre-filled pen delivers precise doses of liraglutide, demonstrating 8% average body weight reduction in 12-month studies while improving metabolic parameters.

Key Benefits
  • Weight Management: 8% average body weight reduction observed in clinical studies
  • Appetite Control: Delays gastric emptying by 31% and enhances satiety signals
  • Metabolic Improvement: Reduces HbA1c by 0.6% and systolic BP by 2.8mmHg
  • Convenient Delivery: Pre-filled multidose pen for easy subcutaneous administration
Professional Administration Guidelines
Dosage Protocol
  • • Route: Subcutaneous injection (abdomen, thigh, or upper arm)
  • • Dose escalation over 4 weeks to maintenance dose
  • • Rotate injection sites to prevent lipodystrophy
Patient Monitoring
  • • Assess weight loss at 16 weeks
  • • Monitor for gastrointestinal adverse effects
  • • Evaluate metabolic parameters regularly
Product Specifications
Active Ingredient
Liraglutide
Excipients
Sodium phosphate dibasic dihydrate, propylene glycol, phenol
Presentation
Pre-filled multidose injection pen
Storage
Refrigerate unopened; room temperature for in-use pen
Shelf Life
Refer to packaging for expiration date
Important Safety Information

Contraindications: Pregnancy, personal/family history of medullary thyroid carcinoma or MEN syndrome

Adverse Effects: Nausea (39.3%), diarrhea (20.9%), constipation (19.4%) in clinical trials

Drug Interactions: May enhance effects of insulin or insulin secretagogues

Professional Note: Discontinue if <4% baseline weight loss after 16 weeks at maximum dose

Professional Protocols

• Saxenda requires prescription and professional medical supervision

• Must be administered as part of comprehensive weight management program

• Follow proper injection technique and site rotation

• Monitor patients for signs of thyroid tumors or pancreatitis

• Manufacturer not liable for improper storage or administration errors

Disclaimer

We are an authorized wholesale distributor of pharmaceutical products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product specifications may vary by market – please confirm actual parameters with our sales team. Product images may differ from actual packaging.

Saxenda™ 3ml Injection Pen

Liraglutide 6 mg/ml

Clinical Overview

Saxenda™ is an FDA-approved GLP-1 receptor agonist for chronic weight management. Clinical trials show 56% of patients achieved ≥5% weight loss at 56 weeks when combined with lifestyle changes. The 3ml pre-filled pen delivers precise doses of liraglutide, demonstrating 8% average body weight reduction in 12-month studies while improving metabolic parameters.

Key Benefits
  • Weight Management: 8% average body weight reduction observed in clinical studies
  • Appetite Control: Delays gastric emptying by 31% and enhances satiety signals
  • Metabolic Improvement: Reduces HbA1c by 0.6% and systolic BP by 2.8mmHg
  • Convenient Delivery: Pre-filled multidose pen for easy subcutaneous administration
Professional Administration Guidelines
Dosage Protocol
  • • Route: Subcutaneous injection (abdomen, thigh, or upper arm)
  • • Dose escalation over 4 weeks to maintenance dose
  • • Rotate injection sites to prevent lipodystrophy
Patient Monitoring
  • • Assess weight loss at 16 weeks
  • • Monitor for gastrointestinal adverse effects
  • • Evaluate metabolic parameters regularly
Product Specifications
Active Ingredient
Liraglutide
Excipients
Sodium phosphate dibasic dihydrate, propylene glycol, phenol
Presentation
Pre-filled multidose injection pen
Storage
Refrigerate unopened; room temperature for in-use pen
Shelf Life
Refer to packaging for expiration date
Important Safety Information

Contraindications: Pregnancy, personal/family history of medullary thyroid carcinoma or MEN syndrome

Adverse Effects: Nausea (39.3%), diarrhea (20.9%), constipation (19.4%) in clinical trials

Drug Interactions: May enhance effects of insulin or insulin secretagogues

Professional Note: Discontinue if <4% baseline weight loss after 16 weeks at maximum dose

Professional Protocols

• Saxenda requires prescription and professional medical supervision

• Must be administered as part of comprehensive weight management program

• Follow proper injection technique and site rotation

• Monitor patients for signs of thyroid tumors or pancreatitis

• Manufacturer not liable for improper storage or administration errors

Disclaimer

We are an authorized wholesale distributor of pharmaceutical products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product specifications may vary by market – please confirm actual parameters with our sales team. Product images may differ from actual packaging.

Reviews

There are no reviews yet.

Be the first to review “Saxenda 3ml Liraglutide Injection Pen Manufacturer for sale”

Related products

Quick links

Get connected with us:

Facebook-square Instagram

Contact us:

  • WhatsApp: +85260252494
  • Email: [email protected]
  • Address: Sea Meadow House P.O. Box 116 Road Town Tortola
  • VG1110 VIRGIN ISLANDS, BRITISH
© 2024
    American Express Diners Club Discover Google Pay Maestro Mastercard Shop Pay Union Pay Visa
en_USEnglish
zh_HKChinese en_USEnglish
Scroll to Top
If necessary, please fill in the following information to contact us
Blank Form (#3)